EXICURE, INC. Investing Cash Flow
EXICURE, INC. (XCUR) reported Investing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- EXICURE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- EXICURE, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00.
- EXICURE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $455.00K.
- EXICURE, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $108.00K.
- EXICURE, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$1.81M.
- EXICURE, INC. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- EXICURE, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$1.08M, a 122.96% decline from fiscal 2022.
- EXICURE, INC. net cash provided by (used in) investing activities for fiscal 2022 was $4.70M, a 89.10% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $455.00K derived: sum of 3 quarters · filed 2026-08-14 | $563.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-29 | $455.00K derived: sum of 2 quarters · filed 2026-05-29 | $563.00K derived: sum of 3 quarters · filed 2026-05-29 | $283.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $563.00K derived: sum of 2 quarters · filed 2026-03-25 | $283.00K derived: sum of 3 quarters · filed 2026-08-14 | -$1.81M 10-K · filed 2026-03-25 |
| 2025-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$172.00K derived: sum of 2 quarters · filed 2026-08-14 | -$2.26M 10-Q · filed 2025-11-07 | -$2.26M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.37M 10-Q · filed 2026-08-14 | -$2.37M derived: sum of 3 quarters · filed 2026-08-14 | -$2.37M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$2.09M 10-Q · filed 2026-05-29 | -$2.09M derived: sum of 2 quarters · filed 2026-05-29 | -$2.09M derived: sum of 3 quarters · filed 2026-05-29 | -$2.09M derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | $711.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $711.00K derived: sum of 3 quarters · filed 2025-08-08 | $711.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2025-06-27 | $711.00K derived: sum of 2 quarters · filed 2025-06-27 | $711.00K derived: sum of 3 quarters · filed 2025-06-27 | -$1.18M derived: sum of 4 quarters · filed 2025-06-27 |
| 2023-12-31 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $711.00K derived: sum of 2 quarters · filed 2025-03-18 | -$1.18M derived: sum of 3 quarters · filed 2025-03-18 | -$1.08M 10-K · filed 2025-03-18 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.90M derived: sum of 2 quarters · filed 2024-11-14 | -$1.79M 10-Q · filed 2024-11-14 | -$1.58M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$1.79M 10-Q · filed 2024-08-13 | -$1.58M derived: sum of 3 quarters · filed 2024-08-13 | -$584.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $106.00K 10-Q · filed 2024-06-17 | $313.00K derived: sum of 2 quarters · filed 2024-06-17 | $1.31M derived: sum of 3 quarters · filed 2024-06-17 | $2.81M derived: sum of 4 quarters · filed 2024-06-17 |
| 2022-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $1.21M derived: sum of 2 quarters · filed 2024-06-06 | $2.70M derived: sum of 3 quarters · filed 2024-06-06 | $4.70M 10-K · filed 2024-06-06 |
| 2022-09-30 | $998.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | $2.49M derived: sum of 2 quarters · filed 2024-06-06 | $4.49M 10-Q · filed 2024-05-16 | $8.60M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | $1.50M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | $3.49M 10-Q/A · filed 2024-06-06 | $7.60M derived: sum of 3 quarters · filed 2024-06-06 | $12.04M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | $2.00M 10-Q/A · filed 2024-06-06 | $6.10M derived: sum of 2 quarters · filed 2024-06-06 | $10.55M derived: sum of 3 quarters · filed 2024-06-06 | $29.78M derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | $4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $8.55M derived: sum of 2 quarters · filed 2023-03-27 | $27.79M derived: sum of 3 quarters · filed 2023-03-27 | $43.09M 10-K · filed 2023-03-27 |
| 2021-09-30 | $4.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $23.68M derived: sum of 2 quarters · filed 2022-11-14 | $38.98M 10-Q · filed 2022-11-14 | $52.45M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $19.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $34.53M 10-Q · filed 2022-08-15 | $48.01M derived: sum of 3 quarters · filed 2022-08-15 | $53.64M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $15.30M 10-Q · filed 2022-05-16 | $28.77M derived: sum of 2 quarters · filed 2022-05-16 | $34.40M derived: sum of 3 quarters · filed 2022-05-16 | $37.94M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $13.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $19.11M derived: sum of 2 quarters · filed 2022-03-25 | $22.64M derived: sum of 3 quarters · filed 2022-03-25 | $10.14M 10-K · filed 2022-03-25 |
| 2020-09-30 | $5.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $9.17M derived: sum of 2 quarters · filed 2021-11-19 | -$3.33M 10-Q · filed 2021-11-19 | -$66.30M derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$8.96M 10-Q · filed 2021-08-12 | -$71.94M derived: sum of 3 quarters · filed 2021-08-12 | -$72.33M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$12.50M 10-Q · filed 2021-05-12 | -$75.47M derived: sum of 2 quarters · filed 2021-05-12 | -$75.87M derived: sum of 3 quarters · filed 2021-05-12 | -$75.93M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$62.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$63.37M derived: sum of 2 quarters · filed 2021-03-11 | -$63.42M derived: sum of 3 quarters · filed 2021-03-11 | -$63.43M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$454.00K derived: sum of 2 quarters · filed 2020-11-12 | -$462.00K 10-Q · filed 2020-11-12 | -$491.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$62.00K 10-Q · filed 2020-08-12 | -$91.00K derived: sum of 3 quarters · filed 2020-08-12 | -$96.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$8.00K 10-Q · filed 2020-05-14 | -$37.00K derived: sum of 2 quarters · filed 2020-05-14 | -$42.00K derived: sum of 3 quarters · filed 2020-05-14 | -$102.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$34.00K derived: sum of 2 quarters · filed 2020-03-10 | -$94.00K derived: sum of 3 quarters · filed 2020-03-10 | -$94.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$65.00K derived: sum of 2 quarters · filed 2019-11-07 | -$65.00K 10-Q · filed 2019-11-07 | -$265.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$60.00K 10-Q · filed 2019-08-08 | -$260.00K derived: sum of 3 quarters · filed 2019-09-23 | -$592.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | -$200.00K derived: sum of 2 quarters · filed 2019-09-23 | -$532.00K derived: sum of 3 quarters · filed 2019-09-23 | -$681.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2017-12-31 | -$200.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | -$532.00K derived: sum of 2 quarters · filed 2019-09-23 | -$681.00K derived: sum of 3 quarters · filed 2019-09-23 | -$926.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | -$332.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$481.00K derived: sum of 2 quarters · filed 2018-11-06 | -$726.00K 10-Q · filed 2018-11-06 | -$805.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | -$149.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$394.00K 10-Q · filed 2018-08-06 | -$473.00K derived: sum of 3 quarters · filed 2018-08-06 | |
| 2017-03-31 | -$245.00K 10-Q · filed 2018-05-15 | -$324.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | -$79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$394.00K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | -$315.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |